IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.

Cory R TrankleJustin M CanadaDinesh KadariyaRoshanak MarkleyHoracio Medina De ChazalJanet PinsonAdam FoxBenjamin W Van TassellAntonio AbbateDaniel Grinnan

Published in: American journal of respiratory and critical care medicine (2019)

Keyphrases

pulmonary arterial hypertension
open label
pulmonary artery
oxidative stress
pulmonary hypertension
clinical trial
phase ii
phase ii study
phase iii
study protocol
randomized controlled trial
squamous cell carcinoma
radiation therapy
coronary artery